The False Claims Act And Health Care: 2023 Recoveries And 2024 Outlook

K&L Gates


At K&L Gates, we foster an inclusive and collaborative environment across our fully integrated global platform that enables us to diligently combine the knowledge and expertise of our lawyers and policy professionals to create teams that provide exceptional client solutions. With offices spanning across five continents, we represent leading global corporations in every major industry, capital markets participants, and ambitious middle-market and emerging growth companies. Our lawyers also serve public sector entities, educational institutions, philanthropic organizations, and individuals. We are leaders in legal issues related to industries critical to the economies of both the developed and developing worlds—including technology, manufacturing, financial services, health care, energy, and more.
On 22 February 2024, the US Department of Justice (DOJ) published the statistics for federal civil fraud recoveries in Fiscal Year (FY) 2023.
United States Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on

On 22 February 2024, the US Department of Justice (DOJ) published the statistics for federal civil fraud recoveries in Fiscal Year (FY) 2023.1 The DOJ announced that the "government and whistleblowers were party to 543 settlements and judgments, the highest number of settlements and judgments in a single year."2 Despite the high number of settlements and judgments, FY 2023 saw the third lowest recovery amount in the last decade. As with prior years, the numbers highlight the general downward trend of False Claims Act (FCA) civil fraud recoveries.3 Remarkably, FY 2023 had the lowest percentage of health care-related new matters since 1995.4 Nevertheless, the US$1.8 billion in settlements and judgments involving the health care industry accounted for more than two-thirds of total recoveries.

In FY 2023, the DOJ highlighted five areas that they described as "key enforcement priorities."5 These included health care fraud, procurement fraud, pandemic fraud, cybersecurity fraud, and individual accountability.6 Within those "key enforcement" areas, the government targeted health insurance companies,7 pharmacies,8 nursing facilities,9 and individual physicians,10 amongst other areas. The government also focused on COVID-19 and opioid epidemic-related fraud.11 As has been the case for at least the last decade and a half, the DOJ reinforced that fighting against fraud and abuse, "'is of paramount importance to the Department of Justice.'"12 A summary of the DOJ's report is further discussed below, as well as in a prior K&L Gates alert.

In this article, K&L Gates will discuss key developments from the first half of FY 2024, including notable settlements related to alleged kickbacks, medically unnecessary services, and controlled substances violations, among others. Additionally, K&L Gates will highlight three health care-related areas worthy of attention in FY 2024. First, after the US Supreme Court issued its decision in United States ex rel. Schutte v. SuperValu in the summer of 2023, it remained uncertain how FCA litigation and interpretation of the FCA's scienter standard would be affected by the case. This article discusses the observable impacts of that decision thus far. Second, the article discusses the circuit split on causation requirements in Anti-Kickback Statute (AKS)-premised FCA actions. And, finally, with the almost endless and continual technological advancements impacting the health care industry, the article delves into the use of artificial intelligence (AI) in health care and fraud enforcement and the DOJ's stance on its use.

To read the full alert, click here.


1. Press Release, U.S. Dep't of Just., False Claims Act Settlements and Judgments Exceed $2.6 Billion in Fiscal Year 2023 (Feb. 22, 2023),

2. Id.

3. U.S. Dep't of Just., Fraud Statistics Overview (Feb. 22, 2023),

4. Id.

5. See supra note 1.

7. See, e.g., Press Release, U.S. Dep't of Just., Cigna Group to Pay $172 Million to Resolve False Claims Act Allegations (Sept. 30, 2023),

8. See, e.g., Press Release, U.S. Dep't of Just., Two Jacksonville Compounding Pharmacies and Their Owner Agree to Pay at Least $7.4 Million to Resolve False Claims Act Allegations (June 15, 2023),

9. See, e.g., Press Release, U.S. Dep't of Just., Landlord and Former Operators of Upstate New York Nursing Home Pay $7,168,000 to Resolve False Claims Act Allegations of Worthless Services Provided to Residents (Feb. 27, 2023),

10. See, e.g., Press Release, U.S. Dep't of Just., Dermatologist Agrees To Pay $6.6 Million To Settle Allegations Of Fraudulent Billing Practices (July 13, 2023),

11. See supra note 1.

12. Id.


The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More